AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Dare Bioscience, Inc. Director's Dealing 2017

Jan 19, 2017

34825_dirs_2017-01-19_002566ac-0891-4f85-a4e5-ebb18e47b66f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2016-10-25

Reporting Person: Eliasof Scott (SVP, Chief Scientific Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100	Indirect

Footnotes

F1: These shares were omitted from the reporting person's original Form 3.